Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model

BACKGROUND: Radical concurrent chemoradiotherapy (CCRT) is frequently used as the first-line treatment for patients with locally advanced esophageal cancer. Unfortunately, some patients respond poorly. To predict response to radical concurrent chemoradiotherapy in pre-treatment patients with esophag...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xu, Zhang, Yuxin, Zhu, Min, Sun, Ruixia, Liu, Lingling, Li, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544369/
https://www.ncbi.nlm.nih.gov/pubmed/37779188
http://dx.doi.org/10.1186/s12880-023-01089-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544369/
https://www.ncbi.nlm.nih.gov/pubmed/37779188
http://dx.doi.org/10.1186/s12880-023-01089-0

Ejemplares similares